article thumbnail

The Moral World of Personality Disorder Assessment

Mad in America

W hen asked about her behavior during a psychiatric assessment for personality disorders, one patient’s response included this description: It was completely crazy. Professionals assess and diagnose the disorder situated in a patient’s mind so that interventions can be targeted to alleviate the disorder.

article thumbnail

“They referred to one of the consumers as a BPD c**t”: uncomfortable narratives of borderline personality disorder

The Mental Elf

Keir Harding looks at an Australian qualitative study that reveals difficult and harmful narratives around people given a diagnosis of 'borderline personality disorder'.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

References NRx Pharmaceuticals, Inc. The FDA has granted Fast Track Designation to NRX-100 for the treatment of acute suicidality, and NRx has also filed a patent application for its novel preservative-free formulation with the US Patent and Trademark Office. Press release. June 23, 2025.

article thumbnail

Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score

Psychiatric Times

References 1. Dr Miller is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times ; Staff Psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts. Griffiths K, Won Y, Lee Z, et al. BMC Psychiatry. 2025;25(1):407.

article thumbnail

How Do Psychiatry Residents Learn Psychopharmacology?

Psychiatric Times

References 1. Dr Stahl is an internationally recognized clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. He is currently a professor at the University of California, San Diego, and serves as Honorary Fellow in psychiatry department at the University of Cambridge. Stahl SM, Davis RL.

Education 123
article thumbnail

The Quiet Crisis in Mental Health: The Medicalization and Deskilling of Psychotherapy

Mad in America

In the biomedical model, this typically refers to constructs labeled as schizophrenia, bipolar disorder, severe major depression, or personality disorders, etc. This can disrupt ones sense of self-integration and/or provoke profound inner torment, which may or may not interfere with major life activities.

Insurance 118
article thumbnail

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Psychiatric Times

References 1. After the FDA rejection of Lykos Therapeutics’ midomafetamine (MDMA)-assisted psychotherapy tempered excitement for psychedelic therapeutics, 2 this positive data could generate new momentum. News release. June 23, 2025.